Heron Therapeutics (HRTX) Leases: 2011-2025
Historic Leases for Heron Therapeutics (HRTX) over the last 7 years, with Sep 2025 value amounting to $708,000.
- Heron Therapeutics' Leases fell 79.59% to $708,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $708,000, marking a year-over-year decrease of 79.59%. This contributed to the annual value of $2.8 million for FY2024, which is 48.75% down from last year.
- As of Q3 2025, Heron Therapeutics' Leases stood at $708,000, which was down 49.46% from $1.4 million recorded in Q2 2025.
- Heron Therapeutics' 5-year Leases high stood at $15.6 million for Q1 2021, and its period low was $708,000 during Q3 2025.
- For the 3-year period, Heron Therapeutics' Leases averaged around $4.0 million, with its median value being $4.1 million (2024).
- Data for Heron Therapeutics' Leases shows a maximum YoY crashed of 79.59% (in 2025) over the last 5 years.
- Heron Therapeutics' Leases (Quarterly) stood at $9.8 million in 2021, then dropped by 22.22% to $7.6 million in 2022, then declined by 28.87% to $5.4 million in 2023, then tumbled by 48.75% to $2.8 million in 2024, then crashed by 79.59% to $708,000 in 2025.
- Its Leases stands at $708,000 for Q3 2025, versus $1.4 million for Q2 2025 and $2.1 million for Q1 2025.